Numab Therapeutics and Kaken Pharmaceutical Announce Licensing and Co-development Agreement for Multispecific Antibody NM81 in Inflammatory Bowel Disease (IBD) Kaken Pharmaceutical in-licenses NM81 across select Asian territories and commits to funding global development into the clinic GlobeNewswire November 13, 2025 HORGEN, Switzerland and TOKYO, Nov. 13, 2025 (GLOBE NEWSWIRE) — Numab Therapeutics AG (“Numab”), a […]

4TEEN4 Extends Series C Financing Round to EUR55 Million, Supporting Expanded Clinical Development of Procizumab in Cardiogenic Shock GlobeNewswire November 13, 2025 Combined capital will support the ongoing Phase 2a clinical trial of procizumab in cardiogenic shock Series C round was supported by both existing and new investors Hennigsdorf/Berlin, November 13, 2025 – 4TEEN4 Pharmaceuticals

ITM Announces FDA Acceptance of New Drug Application (NDA) and PDUFA Date for n.c.a. 177Lu-edotreotide (ITM-11) in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) GlobeNewswire November 13, 2025 Prescription Drug User Fee Act (PDUFA) goal date set for August 28, 2026 Garching / Munich, Germany, November 13, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical

Bilibili Inc. Announces Third Quarter 2025 Financial Results GlobeNewswire November 13, 2025 SHANGHAI, Nov. 13, 2025 (GLOBE NEWSWIRE) — Bilibili Inc. (“Bilibili” or the “Company”) (Nasdaq: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today announced its unaudited financial results for the third quarter ended September

Algo8 Announces Successful Scaling of AI-Powered Process Optimization and Safety with a Global Automotive Component Manufacturer GlobeNewswire November 13, 2025 VANCOUVER, British Columbia, Nov. 13, 2025 (GLOBE NEWSWIRE) — MedBright AI Investments Inc. (CSE: MBAI) (OTCQB: MBAIF) (FSE: Y30), a capital allocator focused on high-growth technology and artificial intelligence companies, is pleased to announce the

WEBTOON Entertainment Inc. to Participate in Upcoming Investor Conferences GlobeNewswire November 13, 2025 LOS ANGELES, Nov. 13, 2025 (GLOBE NEWSWIRE) — WEBTOON Entertainment Inc. (Nasdaq: WBTN) (“WEBTOON Entertainment” or “the Company”), a leading global entertainment company and home to some of the world's largest storytelling platforms, today announced CFO and COO, David J. Lee, will

Ant Digital Technologies (Ant DT) is unveiling its full-scenario financial AI offerings at the Singapore FinTech Festival (SFF) 2025. The company's participation highlights its commitment to advancing artificial intelligence and blockchain applications in financial services and security, while deepening collaboration with partners across Southeast Asia (SEA). Ant DT's full-scenario AI offering integrates end-to-end capabilities –

Ant Digital Technologies (Ant DT) is unveiling its full-scenario financial AI offerings at the Singapore FinTech Festival (SFF) 2025. The company’s participation highlights its commitment to advancing artificial intelligence and blockchain applications in financial services and security, while deepening collaboration with partners across Southeast Asia (SEA). Ant DT’s full-scenario AI offering integrates end-to-end capabilities –

Battery-electric transport unchanged as core of Scania's sustainable transport strategy, but company keeping on top of other technologies and combinations as well. Scania is all-in for electrification but it is also continuing to leave no stone unturned to better understand all forms of sustainable transport, as a recent new research initiative from its Pilot Partner

Dynasty Fine Wines Group Limited ('Dynasty' or the 'Group') (Stock Code: 00828), a premier winemaker in China, has won the Silver Medal in the Sparkling Wine/China category, the Silver Medal in the Dry Wine/China category, and the Bronze Medal in the Medium/China category for its Dynasty Tianyang Winery Jasmine Sparkling Wine, Dynasty Inherit Series –